Cefprozil-d4

• Description :

  Cefprozil-d4 is the deuterium labeled Cefprozi (HY-B0458A) [1]. Cefprozil is a second-generation cephalosporin type antibiotic. Cefprozil exhibits broad-spectrum antibacterial activity, and is orally active. Cefprozil can be used for the study of pharyngitis, tonsillitis, otitis media, and uncomplicated skin infections[2][3].

• CAS Number :

  [1426173-48-9]

• UNSPSC :

  12352005

• Target :

  Antibiotic; Bacterial; Isotope-Labeled Compounds

• Type :

  Isotope-Labeled Compounds

• Related Pathways :

  Anti-infection; Others

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Infection

• Solubility :

  10 mM in DMSO

• Smiles :

  C(O)(=O)C=1N2[C@@]([C@H](NC([C@H](N)C3=C(C(=C(O)C(=C3[2H])[2H])[2H])[2H])=O)C2=O)(SCC1/C=C/C)[H]

• Molecular Formula :

  C18H15D4N3O5S

• Molecular Weight :

  393.45

• References & Citations :

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Wiseman LR, et al., Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential. Drugs. 1993 Feb;45 (2) :295-317.|[3]J C Fung-Tom, et al. Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides. Antimicrob Agents Chemother. 1995 Feb;39 (2) :533-8.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Isotope-Labeled Compounds

• Clinical Information :

  No Development Reported

• Isoform :

  β-lactam